The road from discovery to clinic: Adiponectin as a biomarker of metabolic status

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 6, 2009, Pages 592-595

  Kusminski, C M ^a   Scherer, P E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLITAZONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; DIET; EDEMA; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; META-ANALYSIS AS TOPIC; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

EID: 70450134177     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.155     Document Type: Note

References (16)

1. Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953 (2001).
2. Wu, X., Motoshima, H., Mahadev, K., Stalker, T.J., Scalia, R. & Goldstein, B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355-1363 (2003).
3. Trujillo, M.E. & Scherer, P.E. Adiponectin- journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257, 167-175 (2005).
4. Combs, T.P. et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143, 998-1007 (2002).
5. Fleming, T.R. & DeMets, D.L. Surrogate end points in clinical trials: are we being misled? Ann. Intern. Med. 125, 605-613 (1996).
6. Pajvani, U.B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152-12162 (2004).
7. Wang, Z.V. A. et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell Biol. 27, 3716-3731 (2007).
8. Ridker, P.M., Rifai, N., Pfeffer, M.A., Sacks, F. & Braunwald, E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100, 230-235 (1999).
9. Devaraj, S., Swarbrick, M.M., Singh, U., Adams-Huet, B., Havel, P.J. & Jialal, I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am. J. Clin. Pathol. 129, 815-822 (2008).
10. Pajvani, U.B. et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/ adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073-9085 (2003).
11. von Eynatten, M. et al. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes 58, 2093-2099 (2009).
12. Wagner, J.A. et al. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin. Pharmacol. Ther. 86, 619-625 (2009).
13. Rajala, M.W. & Scherer, P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773 (2003). (Pubitemid 37088727)
14. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749 (1995).
15. Hu, E., Liang, P. & Spiegelman, B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703 (1996).
16. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. & Scherer, P.E. The adipocyte-secreted protein